SENS PubMed Publication Search
Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ 42 Oligomers and Protect Synapses
Front Immunol. 2020 Jan 31;11:49. doi: 10.3389/fimmu.2020.00049.
Songlin Li 1 2 3, Eric Y Hayden 4, Veronica J Garcia 5 6, Dieu-Trang Fuchs 3, Julia Sheyn 3, David A Daley 3, Altan Rentsendorj 3, Tania Torbati 7, Keith L Black 3, Ueli Rutishauser 3 6 8, David B Teplow 4, Yosef Koronyo 3, Maya Koronyo-Hamaoui 3 6
Abstract:
...Here, we utilized photo-induced cross-linking to stabilize pure oligomers and study their effects vs. fibrils on synapses and protection by Aβ-phagocytic macrophages. We found that cortical neurons were more susceptible to Aβ42 oligomers than fibrils, triggering additional neuritic arborization retraction, functional alterations (hyperactivity and spike waveform), and loss of VGluT1- and PSD95-excitatory synapses. Co-culturing neurons with bone marrow-derived macrophages protected synapses against Aβ42 fibrils; moreover, immune activation with glatiramer acetate (GA) conferred further protection against oligomers. Mechanisms involved increased Aβ42 removal by macrophages, amplified by GA stimulation: fibrils were largely cleared through intracellular CD36/EEA1+-early endosomal proteolysis, while oligomers were primarily removed via extracellular/MMP-9 enzymatic degradation. In vivo studies in GA-immunized or CD115+-monocyte-grafted APPSWE/PS1ΔE9-transgenic mice followed by pre- and postsynaptic analyses of entorhinal cortex and hippocampal substructures corroborated our in vitro findings of macrophage-mediated synaptic preservation. Together, our data demonstrate that activated macrophages effectively clear Aβ42 oligomers and rescue VGluT1/PSD95 synapses, providing rationale for harnessing macrophages to treat AD.
PMID: 32082319
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005081/